Data / Form D filings / Mobius Therapeutics LLC
Mobius Therapeutics LLC: Form D filings
Mobius Therapeutics LLC, a pharmaceuticals company in St. Louis, MO, filed 3 Form D notices with the SEC between 2010 and 2013. The latest, on October 25, 2013, reports $5 million sold of a $5 million offering to 19 investors.
Find out what Mobius Therapeutics LLC does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 4041 FOREST PARK AVENUE, St. Louis, MO, 63108
- Phone
- (314) 615-6930
- Industry
- Pharmaceuticals
- Entity type
- Limited Liability Company
- Incorporated in
- Delaware
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1407296
The full lists. Form D filings in Missouri: 379 rows, $18.95, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Oct 25, 2013 | New notice | $5,000,000 | $5,000,000 | $0 | 19 | Oct 10, 2013 | sec.gov |
| Nov 14, 2012 | New notice | $5,000,000 | $1,716,878 | $3,283,122 | 5 | Oct 31, 2012 | sec.gov |
| Dec 1, 2010 | New notice | $1,800,000 | $666,732 | $1,133,268 | 11 | Sep 21, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Edward J. Timm | Executive Officer, Director | |
| James J. Anderson | Executive Officer | |
| Mark J. Wright | Executive Officer, Director | |
| Dean J. Vandekamp | Director |
Other pharmaceuticals companies in Missouri that filed recently
- Immunophotonics, Inc. $10.1 million · Sep 4, 2026
Every Form D from the week of Oct 21, 2013 · All recent filings in Missouri · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what Mobius Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.